Spectinomycin EP Impurity G, with the CAS number 1323437-07-5, is a chemical compound related to spectinomycin, an antibiotic used primarily in the treatment of bacterial infections, particularly those caused by Neisseria gonorrhoeae. As an impurity, it may arise during the synthesis or degradation of spectinomycin and is typically characterized by its specific molecular structure and properties that differentiate it from the parent compound. Impurities like Spectinomycin EP Impurity G can affect the efficacy and safety of pharmaceutical formulations, making their identification and quantification important in quality control processes. The compound's characteristics may include its solubility in various solvents, stability under different conditions, and potential biological activity, although specific details about its pharmacological effects or toxicological profile may not be extensively documented. Regulatory guidelines often require the assessment of such impurities to ensure that they remain within acceptable limits in pharmaceutical products.

Spectinomycin EP Impurity G

1323437-07-5: Spectinomycin EP Impurity G, with the CAS number 1323437-07-5, is a chemical compound related to spectinomycin, an antibiotic used primarily in the treatment of bacterial infections, particularly those caused by Neisseria gonorrhoeae. As an impurity, it may arise during the synthesis or degradation of spectinomycin and is typically characterized by its specific molecular structure and properties that differentiate it from the parent compound. Impurities like Spectinomycin EP Impurity G can affect the efficacy and safety of pharmaceutical formulations, making their identification and quantification important in quality control processes. The compound's characteristics may include its solubility in various solvents, stability under different conditions, and potential biological activity, although specific details about its pharmacological effects or toxicological profile may not be extensively documented. Regulatory guidelines often require the assessment of such impurities to ensure that they remain within acceptable limits in pharmaceutical products.

CAS 1323437-07-5

Spectinomycin EP Impurity G

Spectinomycin EP Impurity G

Ref: ST-EA-CP-S56007